A deep dive into future therapies for microcytic anemias and clinical considerations.
Expert review of hematology(2023)
Abstract
As the genetic and cellular background of dyserythropoiesis will continue to be clarified, collaboration with bioengineering of treatments acting specifically at the protein domain level will continue to provide new therapies in haematology as well as oncology and neurology.
MoreTranslated text
Key words
GDF-11,HSP70,hepcidin,ineffective erythropoiesis,iron metabolism,microcytic anemia
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined